Citation: U. Brinkmann et al., Pharmacogenetics of the human drug-transporter gene MDR1: impact of polymorphisms on pharmacotherapy, DRUG DISC T, 6(16), 2001, pp. 835-839
Authors:
Zanger, UM
Fischer, J
Raimundo, S
Stuven, T
Evert, BO
Schwab, M
Eichelbaum, M
Citation: Um. Zanger et al., Comprehensive analysis of the genetic factors determining expression and function of hepatic CYP2D6, PHARMACOGEN, 11(7), 2001, pp. 573-585
Authors:
Long, T
Klein, K
Fischer, J
Nussler, AK
Neuhaus, P
Hofmann, U
Eichelbaum, M
Schwab, M
Zanger, UM
Citation: T. Long et al., Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver (vol 11, pg 399, 2001), PHARMACOGEN, 11(7), 2001, pp. 643-643
Authors:
Lang, T
Klein, K
Fischer, J
Nussler, AK
Neuhaus, P
Hofmann, U
Eichelbaum, M
Schwab, M
Zanger, UM
Citation: T. Lang et al., Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver, PHARMACOGEN, 11(5), 2001, pp. 399-415
Authors:
Hitzl, M
Drescher, S
van der Kuip, H
Schaffeler, E
Fischer, J
Schwab, M
Eichelbaum, M
Fromm, MF
Citation: M. Hitzl et al., The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56(+) natural killer cells, PHARMACOGEN, 11(4), 2001, pp. 293-298
Authors:
Siegle, I
Fritz, P
Eckhardt, K
Zanger, UM
Eichelbaum, M
Citation: I. Siegle et al., Cellular localization and regional distribution of CYP2D6 mRNA and proteinexpression in human brain, PHARMACOGEN, 11(3), 2001, pp. 237-245
Authors:
Griese, EU
Ilett, KF
Kitteringham, NR
Eichelbaum, M
Powell, H
Spargo, RM
LeSouef, PN
Musk, AW
Minchin, RF
Citation: Eu. Griese et al., Allele and genotype frequencies of polymorphic cytochromes P4502D6, 2C19 and 2E1 in Aborigines from Western Australia, PHARMACOGEN, 11(1), 2001, pp. 69-76
Authors:
Fritz, P
Murdter, TE
Eichelbaum, M
Siegle, I
Weissert, M
Zanger, UM
Citation: P. Fritz et al., Microsomal epoxide hydrolase expression as a predictor of tamoxifen response in primary breast cancer: A retrospective exploratory study with long-term follow-up, J CL ONCOL, 19(1), 2001, pp. 3-9
Authors:
Hustert, E
Zibat, A
Presecan-Siedel, E
Eiselt, R
Mueller, R
Fuss, C
Brehm, I
Brinkmann, U
Eichelbaum, M
Wojnowski, L
Burk, O
Citation: E. Hustert et al., Natural protein variants of pregnane X receptor with altered transactivation activity toward CYP3A4, DRUG META D, 29(11), 2001, pp. 1454-1459
Authors:
Pauli-Magnus, C
Murdter, T
Godel, A
Mettang, T
Eichelbaum, M
Klotz, U
Fromm, MF
Citation: C. Pauli-magnus et al., P-glycoprotein-mediated transport of digitoxin, alpha-methyldigoxin and beta-acetyldigoxin, N-S ARCH PH, 363(3), 2001, pp. 337-343
Citation: A. Geick et al., Nuclear receptor response elements mediate induction of intestinal MDR1 byrifampin, J BIOL CHEM, 276(18), 2001, pp. 14581-14587
Authors:
Coller, JK
Fritz, P
Zanger, UM
Siegle, I
Eichelbaum, M
Kroemer, HK
Murdter, TE
Citation: Jk. Coller et al., Distribution of microsomal epoxide hydrolase in humans: An immunohistochemical study in normal tissues, and benign and malignant tumours, HISTOCHEM J, 33(6), 2001, pp. 329-336
Authors:
Schwab, M
Schaeffeler, E
Marx, C
Zanger, U
Aulitzky, W
Eichelbaum, M
Citation: M. Schwab et al., Shortcoming in the diagnosis of TPMT deficiency in a patient with Crohn's disease using phenotyping only, GASTROENTY, 121(2), 2001, pp. 500-501
Authors:
von Richter, O
Greiner, B
Fromm, MF
Fraser, R
Omari, T
Barclay, ML
Dent, J
Somogyi, AA
Eichelbaum, M
Citation: O. Von Richter et al., Determination of in vivo absorption, metabolism, and transport of drugs bythe human intestinal wall and liver with a novel perfusion technique, CLIN PHARM, 70(3), 2001, pp. 217-227
Authors:
Busse, D
Fromm, MF
Morike, K
Drescher, S
Kuhlkamp, V
Eichelbaum, M
Citation: D. Busse et al., Disposition and pharmacologic effects of R/S-verapamil in patients with chronic atrial fibrillation: An investigation comparing single and multiple dosing, CLIN PHARM, 69(5), 2001, pp. 324-332
Authors:
Cascorbi, I
Gerloff, T
Johne, A
Meisel, C
Hoffmeyer, S
Schwab, M
Schaeffeler, E
Eichelbaum, M
Brinkmann, U
Roots, I
Citation: I. Cascorbi et al., Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects, CLIN PHARM, 69(3), 2001, pp. 169-174
Authors:
Hofmann, U
Pecia, M
Heinkele, G
Dilger, K
Kroemer, HK
Eichelbaum, M
Citation: U. Hofmann et al., Determination of propafenone and its phase I and phase II metabolites in plasma and urine by high-performance liquid chromatography-electrospray ionization mass spectrometry, J CHROMAT B, 748(1), 2000, pp. 113-123
Authors:
von Richter, O
Eichelbaum, M
Schonberger, F
Hofmann, U
Citation: O. Von Richter et al., Rapid and highly sensitive method for the determination of verapamil, [H-2(7)]verapamil and metabolites in biological fluids by liquid chromatography-mass spectrometry, J CHROMAT B, 738(1), 2000, pp. 137-147
Authors:
Raimundo, S
Fischer, R
Eichelbaum, M
Griese, EU
Schwab, M
Zanger, UM
Citation: S. Raimundo et al., Elucidation of the genetic basis of the common 'intermediate metabolizer' phenotype for drug oxidation by CYP2D6, PHARMACOGEN, 10(7), 2000, pp. 577-581
Authors:
Bohnenstengel, F
Friedel, G
Ritter, CA
McClellan, M
Fritz, P
Eichelbaum, M
Linder, A
Toomes, H
Dierkesmann, R
Kroemer, HK
Citation: F. Bohnenstengel et al., Variability of cyclophosphamide uptake into human bronchial carcinoma: consequences for local bioactivation, CANC CHEMOT, 45(1), 2000, pp. 63-68